Vaccines against Human Respiratory Syncytial Virus-Reference-Cited by-同舟云学术

Vaccines against Human Respiratory Syncytial Virus

Published:2006 Issue: Volume: Page:233-278
ISSN:0168-7069
Container-title:Respiratory Syncytial Virus
language:
Short-container-title:

Author:

Collins Peter L.,Murphy Brian R.

Publisher

Elsevier

Reference182 articles.

1. American Academy of Pediatrics, C. O. I. D. A. C. O. F. A. N. Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics 1996; 97: 137.

2. American Academy of Pediatrics, C. O. I. D. A. C. O. F. A. N. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics 2003; 112: 1442.

3. Gene-gun DNA vaccination aggravates respiratory syncytial virus-induced pneumonitis;Bartholdy;J Gen Virol,2004

4. Human parainfluenza virus type I (HPIV1) vaccine candidates designed by reverse genetics are attenuated and efficacious in African green monkeys;Bartlett;Vaccine,2005

5. Immunization with a peptide derived from the G glycoprotein of bovine respiratory syncytial virus (BRSV) reduces the incidence of BRSV-associated pneumonia in the natural host;Bastien;Vaccine,1997

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in Children;The Journal of Infectious Diseases;2018-03-02

2. Measles Vaccine;Uirusu;2009